Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1989-07-13
1992-05-19
Nucker, Christine
Drug, bio-affecting and body treating compositions
Lymphokine
424 852, 424 854, 424 855, 424 856, 424 857, 424 858, 530351, 530395, 530405, 530409, 5303911, 5303917, 5303919, 53038823, 5303892, 514 2, 514 8, 514 12, 514 21, 930142, 930143, A61K 3766, A61K 3944, C07K 1526, C07K 1702
Patent
active
051147114
ABSTRACT:
Described is a new class of polypeptide cell modulators characterized by being composed of two covalently linked cell modulators in a linear polypeptide sequence. Such dual function polypeptides have new and particularly useful activities when the component polypeptide cell modulators are interferons, lymphokines or cytotoxins which act through different and specific cell receptors to initiate complementary biological activities.
REFERENCES:
patent: Re32637 (1988-04-01), Ishida
patent: 4468382 (1984-08-01), Bacha et al.
Rudinger in J. A. Parsons ed Peptide Hormones Univ. Park Press Baltimore, Jun. 1976 pp. 1-7.
CA 106(9):159 abstract #62196j.
Shepard et al (1984) Nature 294:563-565.
Bell Leslie D.
McCullagh Keith G.
Porter Alan G.
G. D. Searle & Co.
Kanady Mary Jo
Kim Kay
Matukaitis Paul D.
Nucker Christine
LandOfFree
Covalently linked polypeptide cell modulators such as interferon does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Covalently linked polypeptide cell modulators such as interferon, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Covalently linked polypeptide cell modulators such as interferon will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2416395